Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

High-throughput ultrasound-based volumetric 3D printing for tissue engineering

Project description

The future of cardiac tissue engineering

Heart disease is a leading cause of death, and better tools are needed to test treatments effectively. Myocardial cell constructs, like organoids or organs-on-chips, show promise as alternatives to animal testing, but they often fail to mimic the intricate structure of natural heart tissue. While 3D bioprinting holds potential, current methods are either too slow or incapable of producing the detailed structures required. In this context, the EIC-funded SONOCRAFT project will use ultrasonic particle manipulation and rapid volumetric 3D printing to create centimetre-long, aligned cardiac constructs within hydrogels, complete with artificial vasculature for oxygen and nutrient flow. This platform, equipped with advanced features like precise cell patterning, aims to transform tissue engineering, drug testing, and regenerative medicine.

Objective

Cardiovascular diseases are the leading cause of death globally. Efficient drug testing and disease models are needed to reduce their death toll. Myocardial cell constructs, e.g. spheroids, organoids, or organs on a chip, hold promise as disease models and can reduce animal testing. Unfortunately, cell constructs often lack the natural spatial complexity of their in-vivo counterparts, and consequently the cells remain immature and non-differentiated.
Although, 3D printing offers great flexibility regarding the printed structure some limitations apply: the printing process is either slow, or not suited for printing the small-scale nested structures needed to create viable and functional myocardial cell constructs. To 3D bio print viable myocardial cell constructs, we must therefore break through several roadblocks limiting the potential of bioprinting.
Our solution, coined SONOCRAFT, combines rapid volumetric 3D printing technology with ultrasonic particle manipulation to create centimetre-long aligned cardiac constructs within hydrogels. An artificial vasculature, incorporated within the hydrogel matrix, assures perfusion with oxygen and nutrients. Acoustic particle manipulation our tool of choice for cell manipulation as it is cheap, biocompatible, label-free and achieves the required resolution.
To reach the objectives SonoPrint is equipped with a range of advanced features: (i) an acoustophoresis chamber for precise cell patterning in 3D; (ii) microfluidic nozzles for injecting multiple cell types; (iii) moveable printheads for flexible cell deposition; (iv) a temperature-controlled cell culture incubator; and (v) full automation for user-friendly operation. The visionary SONOCRAFT holds potential to transform tissue engineering, regenerative medicine, drug screening, and disease modelling with its technological breakthroughs overcoming current limitations in the field.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2024-PATHFINDEROPEN-01

See all projects funded under this call

Coordinator

UNIVERSITAT DE BARCELONA
Net EU contribution
€ 882 000,00
Address
GRAN VIA DE LES CORTS CATALANES 585
08007 Barcelona
Spain
Region
Este Cataluña Barcelona
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 882 000,00

Participants (6)

Partners (2)